New Solution Enabling the Early Detection of Alzheimer’s Disease is Being Developed With Hungarian Participation

A screening platform based on artificial intelligence that enables the early detection of Alzheimer’s disease is being developed with the participation of scientific, business and clinical organizations from 15 countries with the support of the European Union’s Horizon Europe program – the Hungarian member of the collaboration, Pharmacoidea Kft. from Szeged, informed MTI.